NCT02537808View on ClinicalTrials.gov

Non-interventional Study of Lenalidomide / Dexamethasone as First Line Therapy in Patients With Multiple Myeloma

CompletedOBSERVATIONAL

Enrollment

172

Participants

Timeline

Start Date

June 23, 2015

Primary Completion Date

September 30, 2020

Study Completion Date

September 13, 2023

Conditions

Multiple Myeloma

Trial Locations (1)

44787

Hämatologisch-Onkologische Schwerpunktpraxis, Bochum

All Listed Sponsors

lead

iOMEDICO AG

INDUSTRY

NCT02537808 - Non-interventional Study of Lenalidomide / Dexamethasone as First Line Therapy in Patients With Multiple Myeloma | Biotech Hunter | Biotech Hunter